Cargando…
PIMREG, a Marker of Proliferation, Facilitates Aggressive Development of Cholangiocarcinoma Cells Partly Through Regulating Cell Cycle-Related Markers
BACKGROUND: Phosphatidylinositol binding clathrin assembly protein interacting mitotic regulator (PIMREG) is a protein associated with cell proliferation. Its aberrant expression was reported to be correlated with the development in multiple tumors. However, its role in cholangiocarcinoma (CAA) has...
Autores principales: | Jiang, Zhao-Ming, Li, Hong-Bin, Chen, Shu-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768323/ https://www.ncbi.nlm.nih.gov/pubmed/33356974 http://dx.doi.org/10.1177/1533033820979681 |
Ejemplares similares
-
Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling
por: Jiang, Lili, et al.
Publicado: (2019) -
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021) -
Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
por: Zhu, Hua, et al.
Publicado: (2022) -
High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma
por: Jiang, Feng, et al.
Publicado: (2021) -
Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation
por: Zhao, Wenjing, et al.
Publicado: (2023)